Dawn Carter Bir

Insider Reports History

Location
Foster City, CA
Signature
/s/ Eric J. Schoen by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dawn Carter Bir:

Company Role Class Num Shares Value Price $ Report Date Ownership
SOLENO THERAPEUTICS INC Director Common Stock 16,991 $1,295,733 $76.26 05 Jun 2025 Direct
GERON CORP Interim President and CEO, Director Stock Option (right to buy) 180,000 21 May 2025 Direct
CASSAVA SCIENCES INC Director Stock Option (Right to Buy) 53,000 21 Oct 2025 Direct
REATA PHARMACEUTICALS INC Chief Commercial Officer Class A common stock 0 $172.03 26 Sep 2023 Direct
REATA PHARMACEUTICALS INC Chief Commercial Officer Employee Stock Option (right to buy) 0 26 Sep 2023 Direct

Insider Reports Filed by Dawn Carter Bir

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SAVA CASSAVA SCIENCES INC 21 Oct 2025 1 $0 4 Director 22 Oct 2025, 18:15
SAVA CASSAVA SCIENCES INC 21 Oct 2025 0 $0 3 Director 22 Oct 2025, 18:11
SLNO SOLENO THERAPEUTICS INC 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 19:19
GERN GERON CORP 21 May 2025 1 $0 4 Interim President and CEO, Director 22 May 2025, 17:06
SLNO SOLENO THERAPEUTICS INC 15 Aug 2024 1 $0 4 Director 16 Aug 2024, 18:18
SLNO SOLENO THERAPEUTICS INC 15 Aug 2024 0 $0 3 Director 16 Aug 2024, 18:16
GERN GERON CORP 09 May 2024 1 $0 4 Director 10 May 2024, 16:05
/report/000089924323019542-bir-dawn-carter-2023-09-26 REATA PHARMACEUTICALS INC 26 Sep 2023 9 $0 4 Chief Commercial Officer 26 Sep 2023, 16:30
/report/000120919123046282-bir-dawn-carter-2023-08-15 REATA PHARMACEUTICALS INC 15 Aug 2023 2 -$203,409 4 Chief Commercial Officer 17 Aug 2023, 16:35
/report/000120919123043986-bir-dawn-carter-2023-07-28 REATA PHARMACEUTICALS INC 28 Jul 2023 5 -$5,678,628 4 Chief Commercial Officer 01 Aug 2023, 16:29
/report/000120919123041927-bir-dawn-carter-2023-07-06 REATA PHARMACEUTICALS INC 06 Jul 2023 1 $0 4 Chief Commercial Officer 10 Jul 2023, 16:42
GERN GERON CORP 31 May 2023 1 $0 4 Director 02 Jun 2023, 20:53
/report/000120919123030167-bir-dawn-carter-2023-05-15 REATA PHARMACEUTICALS INC 15 May 2023 2 -$109,829 4 Chief Commercial Officer 17 May 2023, 16:21
/report/000120919123018924-bir-dawn-carter-2023-03-13 REATA PHARMACEUTICALS INC 13 Mar 2023 1 -$808,436 4 Chief Commercial Officer 15 Mar 2023, 16:44
/report/000120919123017258-bir-dawn-carter-2023-03-06 REATA PHARMACEUTICALS INC 06 Mar 2023 13 -$6,609,121 4 Chief Commercial Officer 08 Mar 2023, 16:17
/report/000120919123016278-bir-dawn-carter-2023-03-03 REATA PHARMACEUTICALS INC 03 Mar 2023 1 -$191,148 4 Chief Commercial Officer 06 Mar 2023, 15:28
/report/000120919123000872-bir-dawn-carter-2023-01-03 REATA PHARMACEUTICALS INC 03 Jan 2023 2 $0 4 Chief Commercial Officer 04 Jan 2023, 15:11
GERN GERON CORP 10 May 2022 1 $0 4 Director 11 May 2022, 18:14
/report/000120919122001638-bir-dawn-carter-2022-01-03 REATA PHARMACEUTICALS INC 03 Jan 2022 2 $0 4 Chief Commercial Officer 05 Jan 2022, 15:09
GERN GERON CORP 11 May 2021 1 $0 4 Director 13 May 2021, 21:23